Latest Strategy News

Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Cobalt Blue Holdings has raised $5.3 million through a discounted placement to advance its Kwinana Cobalt Refinery and Broken Hill projects, reinforcing its position in the critical minerals sector.

Horizon Minerals has formalised a key Land Use Agreement with the Marlinyu Ghoorlie Native Title Claimant Group, setting a cooperative framework for heritage protection and project development across its extensive eastern goldfields tenure.

American Rare Earths has appointed mining veteran Mark Wall as CEO to lead its transition from exploration to production, focusing on advancing its flagship Halleck Creek project and expanding its U.S. market presence.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

Venus Metals Corporation has issued a firm recommendation to reject QGold Pty Ltd’s unsolicited $0.17 per share takeover offer, arguing it undervalues key assets and offers no premium. The board highlights significant upside potential in its portfolio and warns shareholders against accepting an opportunistic bid.

Desert Metals has raised $1.25 million to advance drilling and sampling at its promising gold projects in Côte d’Ivoire, aiming to unlock new resource potential in 2026.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.

Talius Group appoints seasoned executive Pat Howard as CEO, with founder Graham Russell shifting to a strategic growth role, signalling a new phase of expansion and innovation.

Critical Resources Limited has partnered with Canada's Pathway Group to accelerate permitting, funding, and stakeholder engagement for its Mavis Lake Lithium Project, aiming to cement its role in North America's lithium supply chain.

CLINUVEL Pharmaceuticals is significantly expanding its VALLAURIX RD&I Centre in Singapore with a five-year strategic investment, aiming to become a global leader in advanced peptide drug delivery.